10 December 2024 : Clinical Research
Evaluating Lipiodol Efficacy in Proximal Tubal Occlusion Treatment: Single-Center Experience and Literature Review
Maciej SzmyginDOI: 10.12659/MSM.946266
Med Sci Monit 2024; 30:e946266
Table 1 Clinical, procedural, and reproductive outcomes following the procedures.
| Clinical data, n=96 | |
|---|---|
| Mean age±SD (years, range) | 33±4. (range from 26 to 45) |
| Primary | 76, 79% |
| Secondary | 20, 21% |
| Duration (years, range) | 2.8 (1 to 11) |
| HSG and/or sono-HSG | 63, 66% |
| Laparoscopy and HSG | 18, 19% |
| Laparoscopy | 15 (15%) |
| Ovulation induction | 35, 36% |
| In-vitro fertilization | 6, 6% |
| Intrauterine insemination | 5, 5% |
| Other | 23, 24% |
| Endocrinopathies | 20, 21% |
| Endometriosis | 8, 8% |
| Unilateral oophorectomy | 6, 6% |
| Bicornuate uterus | 2, 2% |
| Oligospermia | 25, 26% |
| Varicoceles | 5, 5% |
| Complete patency | 92, 96% |
| Partial patency | 4, 4% |
| Selective salpingography | 67, 70% |
| Salpingography+catheterization | 29, 30% |
| Radiation mGy±SD (range) | 37.5±40.8 mGy (4 to 229) |
| Pregnancy | 34, 36% |
| Miscarriage | 5, 5% |
| Ectopic pregnancy | 1, 1% |
| Lost in the follow-up | 1, 1% |






